TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/23 18:46 | 3/2/23 | ATRA | Atara Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dupont Jakob | CA | O | EVP,Head | S | -18 | 3.63 | 0 | -5 | -2 | 291 | D | ||||||||||||||
11/18/22 20:13 | 11/16/22 | ATRA | Atara Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dupont Jakob | CA | O | EVP,Head | S | -19 | 4.49 | 0 | -4 | -3 | 155 | D | ||||||||||||||
8/18/22 18:21 | 8/16/22 | ATRA | Atara Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dupont Jakob | CA | O | EVP,Head | S | -21 | 5.03 | 0 | -4 | -3 | 159 | D | ||||||||||||||
5/19/22 17:08 | 5/17/22 | ATRA | Atara Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Dupont Jakob | CA | O | EVP,Head | S | -21 | 5.32 | 0 | -4 | -2 | 163 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |